Zai Lab Limited
ZLAB
$35.35
$0.661.90%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 65.68% | 47.72% | 45.95% | 38.78% | 5.16% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 65.68% | 47.72% | 45.95% | 38.78% | 5.16% |
Cost of Revenue | -11.98% | 22.14% | 54.67% | 26.44% | 21.98% |
Gross Profit | 135.61% | 95.78% | 33.89% | 84.10% | -63.66% |
SG&A Expenses | -0.01% | -1.94% | 17.36% | 10.69% | 14.72% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -6.77% | 11.34% | 4.87% | 19.00% | 18.71% |
Operating Income | 45.24% | 18.81% | 23.55% | -1.13% | -27.43% |
Income Before Tax | 14.40% | 39.74% | 33.60% | -8.80% | -54.49% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 14.40% | 39.74% | 33.60% | -8.80% | -54.49% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 14.40% | 39.74% | 33.60% | -8.80% | -54.49% |
EBIT | 45.24% | 18.81% | 23.55% | -1.13% | -27.43% |
EBITDA | 46.63% | 20.42% | 25.01% | -0.65% | -27.69% |
EPS Basic | 19.11% | 40.53% | 34.35% | -7.51% | -52.82% |
Normalized Basic EPS | 22.97% | 41.30% | 46.23% | -16.29% | -52.75% |
EPS Diluted | 19.11% | 40.53% | 34.35% | -7.51% | -52.82% |
Normalized Diluted EPS | 22.97% | 41.30% | 46.23% | -16.29% | -52.75% |
Average Basic Shares Outstanding | 5.81% | 1.33% | 1.15% | 1.22% | 1.09% |
Average Diluted Shares Outstanding | 5.81% | 1.33% | 1.15% | 1.22% | 1.09% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |